FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to use of lithium folate of general formula Li2C19H17N7O6⋅5H2O as an immunomodulatory agent.
EFFECT: wider range of immunomodulatory agents.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOSTIMULATING AND ANTIOXIDANT COMPOSITION | 2008 |
|
RU2372081C1 |
IMMUNOMODULATORY AND ANTI-INFECTIOUS COMPOSITION | 2011 |
|
RU2448691C1 |
ANTIOXIDANT AND IMMUNOSTIMULATING COMPOSITION | 2010 |
|
RU2444358C1 |
IMMUNOSTIMULATING DRUG | 2012 |
|
RU2480223C1 |
COMPOSITION WITH IMMUNOPOTENTIATING PROPERTIES | 2006 |
|
RU2348416C2 |
METHOD OF IMMUNOREGULATORY GLOBULIN PREPARING | 1996 |
|
RU2122863C1 |
AGENT FOR USING AT COMPLEX TREATMENT OF PATIENTS WITH UTERUS AND LUNG CANCER | 1992 |
|
RU2092186C1 |
IMMUNOSUPPRESSANT | 2011 |
|
RU2448696C1 |
COMPOUND STIMULATING DURING EXPERIMENT SYNTHESIS OF IMMUNOGLOBULINS | 1995 |
|
RU2108096C1 |
METHOD FOR PROPHYLAXIS OF IMMUNODEFICIENCY | 2005 |
|
RU2301092C2 |
Authors
Dates
2025-01-14—Published
2024-05-22—Filed